Bvf Inc Eledon Pharmaceuticals, Inc. Transaction History
Bvf Inc
- $2.54 Billion
- Q2 2025
A detailed history of Bvf Inc transactions in Eledon Pharmaceuticals, Inc. stock. As of the latest transaction made, Bvf Inc holds 6,293,282 shares of ELDN stock, worth $16.7 Million. This represents 0.67% of its overall portfolio holdings.
Number of Shares
6,293,282
Previous 6,293,282
-0.0%
Holding current value
$16.7 Million
Previous $21.3 Million
20.06%
% of portfolio
0.67%
Previous 0.94%
Shares
6 transactions
Others Institutions Holding ELDN
# of Institutions
86Shares Held
36.8MCall Options Held
48.5KPut Options Held
30.3K-
Ra Capital Management, L.P. Boston, MA3.57MShares$9.49 Million0.21% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.32MShares$8.83 Million0.0% of portfolio
-
First Light Asset Management, LLC Edina, MN2.6MShares$6.92 Million1.08% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L31.96MShares$5.21 Million1.46% of portfolio
-
Woodline Partners LP San Francisco, CA1.67MShares$4.45 Million0.03% of portfolio
About Eledon Pharmaceuticals, Inc.
- Ticker ELDN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,756,800
- Market Cap $36.6M
- Description
- Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that i...